A PYMNTS Company

US: Baxter puts price-fixing woes behind with $64M settlement

By  |  April 21, 2014

Baxter International has finally put a price-fixing lawsuit against the health care giant behind as a federal judge finalized the company’s $64 million settlement.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Reports say the company’s offer puts the total amount of damages recovered by the plaintiffs in the case to $128 million.

    The class action sued accused Baxter and other companies of colluding to fix the price of a blood plasma derivative, collaborating to restrict its supply to hike prices between 2003 and 2009.

    Among the companies that have settled include CSL Limited, CSL Behring, CSL Plasma, and the Plasma Protein Therapeutics Association. Those firms similarly settled for $64 million, an offer that was finalized earlier this yea by US District Judge Joan B. Gottschall.

    Full Content: Market Watch

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.